We are live on ! Find out more
Mitsubishi UFJ Asset Management

Mitsubishi UFJ Asset Management Portfolio holdings

AUM $180B
1-Year Est. Return 37.51%
This Fund
S&P 500
This Quarter Est. Return
+10.79%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$10.9B
AUM Growth
+$2.13B
Cap. Flow
+$1.33B
Cap. Flow %
12.27%
Top 10 Hldgs %
22.74%
Holding
1,019
New
12
Increased
856
Reduced
87
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 23%
2 Healthcare 12.99%
3 Consumer Discretionary 12.21%
4 Financials 10.67%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAC icon
876
Macerich
MAC
$6.94B
$237K ﹤0.01%
34,846
XNCR icon
877
Xencor
XNCR
$1.64B
$236K ﹤0.01%
6,077
-17
-0.3% -$591
ADEA icon
878
Adeia
ADEA
$3.06B
$234K ﹤0.01%
76,832
+18,556
+32% +$68.5K
SAIC icon
879
Saic
SAIC
$5.31B
$234K ﹤0.01%
2,983
+161
+6% +$12.7K
RCKT icon
880
Rocket Pharmaceuticals
RCKT
$380M
$232K ﹤0.01%
10,135
+115
+1% +$2.83K
B
881
DELISTED
Barnes Group Inc.
B
$231K ﹤0.01%
6,464
-1,936
-23% -$73.5K
PSN icon
882
Parsons
PSN
$5.14B
$229K ﹤0.01%
6,820
+399
+6% +$13.8K
GMED icon
883
Globus Medical
GMED
$11.5B
$228K ﹤0.01%
4,601
-1,551
-25% -$80K
ARWR icon
884
Arrowhead Research
ARWR
$12.6B
$227K ﹤0.01%
5,283
+76
+1% +$3.28K
UHT
885
Universal Health Realty Income Trust
UHT
$574M
$226K ﹤0.01%
3,968
+459
+13% +$31K
ATRA icon
886
Atara Biotherapeutics
ATRA
$79.3M
$222K ﹤0.01%
685
-1
-0.1% -$341
RARE icon
887
Ultragenyx Pharmaceutical
RARE
$2.62B
$222K ﹤0.01%
2,698
+38
+1% +$3.15K
FOLD
888
DELISTED
Amicus Therapeutics
FOLD
$218K ﹤0.01%
15,419
-374
-2% -$5.45K
PAGS icon
889
PagSeguro Digital
PAGS
$2.5B
$217K ﹤0.01%
5,747
+1,996
+53% +$77.5K
CUB
890
DELISTED
Cubic Corporation
CUB
$210K ﹤0.01%
3,609
+223
+7% +$10.5K
BLKB icon
891
Blackbaud
BLKB
$2.07B
$208K ﹤0.01%
3,732
+1,294
+53% +$77.5K
LMNX
892
DELISTED
Luminex Corp
LMNX
$207K ﹤0.01%
7,895
+440
+6% +$13.5K
UNM icon
893
Unum
UNM
$14.4B
$206K ﹤0.01%
12,232
+3,899
+47% +$69.3K
ACIW icon
894
ACI Worldwide
ACIW
$5.26B
$205K ﹤0.01%
7,855
+2,773
+55% +$76.8K
RTL
895
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$203K ﹤0.01%
32,376
EDIT icon
896
Editas Medicine
EDIT
$452M
$200K ﹤0.01%
7,128
+88
+1% +$2.87K
CDXS icon
897
Codexis
CDXS
$161M
$199K ﹤0.01%
16,986
-193
-1% -$2.4K
NTLA icon
898
Intellia Therapeutics
NTLA
$1.68B
$198K ﹤0.01%
9,938
+121
+1% +$2.52K
BPYU
899
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$197K ﹤0.01%
16,070
SE icon
900
Sea Limited
SE
$80.7B
$195K ﹤0.01%
1,264
+444
+54% +$59.9K

Similar funds

Mitsubishi UFJ Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Mitsubishi UFJ Asset Management held 1,019 positions worth $10.9B, up 24% from $8.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mitsubishi UFJ Asset Management deployed $1.33B of net new capital in Q3 2020, opening 12 new positions and adding to 856 existing holdings. Its largest new stake was Envista: 114,700 shares worth $2.83M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $29.6M trimmed.

  • Mitsubishi UFJ Asset Management's largest Q3 2020 buy was Envista: 114,700 shares worth $2.83M.
  • Mitsubishi UFJ Asset Management added most to Microsoft in Q3 2020, an estimated $63.6M increase.
  • Mitsubishi UFJ Asset Management's biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $29.6M.
  • Mitsubishi UFJ Asset Management fully exited Atlassian in Q3 2020, selling an estimated $6.74M.
  • Mitsubishi UFJ Asset Management's ten largest holdings make up 23% of its $10.9B portfolio in Q3 2020.
  • Mitsubishi UFJ Asset Management opened 12 new positions and closed 15 in Q3 2020.
  • Mitsubishi UFJ Asset Management's portfolio value rose 24% quarter-over-quarter to $10.9B.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.